Diltiazem Hydrochloride Tablet, Extended Release
Product Images NDC 69097-993

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 69097-993). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

120mg_90.jpg (120mg 90)

120mg_90.jpg (120mg 90)
Diftazem Hydrochloride Extended-Release Tablets by Cipla are available in a 120mg dosage. They are designed to slowly release the active ingredient over time for the treatment of a specific condition.*
FDA Label Image

180_30.jpg (180 30)

FDA Label Image

Image Description (180 90)

FDA Label Image

240_30.jpg (240 30)

FDA Label Image

240_90.jpg (240 90)

FDA Label Image

300_30.jpg (300 30)

FDA Label Image

300mg_90.jpg (300 90)

FDA Label Image

360mg-30s.jpg (360 30)

FDA Label Image

360_90.jpg (360 90)

FDA Label Image

420_30.jpg (420 30)

FDA Label Image

420_90.jpg (420 90)

FDA Label Image

Diltiazem_120mg 30.jpg (Diltiazem 120mg 30)

FDA Label Image

Structure.jpg (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.